Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II studyWalter, T.A. ; Lievre, A. ; Coriat, R. ; Malka, D. ; El Hajbi, F. ; Di Fiore, F. ; Dhome, O. Hentic ; Smith, D. ; Hautefeuille, V. ; Roquin, G. ; Perrier, M. ; Dahan, L. ; V. Granger ; Sobhani, I. ; Mineur, L. ; Niccoli, P. ; Assenat, E. ; Le Malicot, K. ; Lepage, C. ; Bohas, C. LombardAnnals of oncology, 2022, Vol.33, p.S1412 [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Ata de Congresso
|
Weekly Etoposide and Platinum in Small-Cell Lung Cancer: Hope and Scope for Fragile PatientsSundriyal, Deepak ; Kumar, Parmod ; Gogisetti, Yeswanth ; Sehrawat, AmitIndian Journal of Medical and Paediatric Oncology, 2021, Vol.42 (2) [Periódico revisado por pares]A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. LtdTexto completo disponível |
|
3 |
Material Type: Ata de Congresso
|
The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancerTandstad, Torgrim ; Stahl, Olof ; Dahl, Olav ; Glimelius, Ingrid ; Haugnes, Hege Sagstuen ; Karlsdottir, Asa ; Langberg, Carl Wilhelm ; Soderstrom, Karin ; Solberg, Arne ; Stierner, Ulrika K. ; Wall, Najme ; Cohn-Cedermark, Gabriella ElisabethJOURNAL OF CLINICAL ONCOLOGY, 2017, Vol.35 (15_suppl), p.TPS4593-TPS4593 [Periódico revisado por pares]Texto completo disponível |
|
4 |
Material Type: Ata de Congresso
|
Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN studyBischoff, H ; Paz-Ares, L ; Chen, Y ; Reinmuth, N ; Hotta, K ; Trukhin, D ; Statsenko, G ; Hochmair, M J ; Özgüroğlu, M ; Li, J H ; Voitko, O ; Poltoratskiy, A ; Verderame, F ; Havel, L ; Bondarenko, I ; Losonczy, G ; Conev, N ; Broadhurst, H ; Dalvi, T ; Jiang, H ; Golgman, J W ; Alt, JPneumologie, 2022, Vol.76 (S 01) [Periódico revisado por pares]Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme VerlagTexto completo disponível |
|
5 |
Material Type: Ata de Congresso
|
Analysis of stably expressed genes with low-dose etoposide for toxicological studies in osteosarcomaFerreira de Oliveira, JMP ; Almeida, L ; Pimentel, F ; Van Zoelen, EJJ ; Santos, CPlanta Medica, 2014, Vol.80 (16) [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Ata de Congresso
|
Cytotoxic effects of ethyl acetate extract of Sambucus ebulus compared with Etoposide on normal and cancer cell linesSaeedi Saravi, SS ; Shokrzadeh, M ; Mirzayi, MPlanta Medica, 2009, Vol.75 (9) [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Ata de Congresso
|
An integrated analysis of genome-wide DNA methylation and genetic variants underlying etoposide-induced cytotoxicity in European and African populationsLi, Ruowang ; Kim, Dokyoon ; Dudek, Scott M. ; Ritchie, Marylyn D. Esparcia-Alcázar, Anna I. ; Mora, Antonio M.Applications of Evolutionary Computation, p.928-938 [Periódico revisado por pares]Berlin, Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
8 |
Material Type: Ata de Congresso
|
Naked mole rat cells display more efficient DNA excision repair and higher resistance to toxic impacts than mouse cellsEvdokimov, Alexey ; Petruseva, Irina ; Popov, Aleksei ; Koval, Olga ; Lavrik, Olga Bazarnyi, V. ; Kovtun, O.BIO Web of Conferences, 2020, Vol.22, p.1017 [Periódico revisado por pares]Les Ulis: EDP SciencesTexto completo disponível |
|
9 |
Material Type: Ata de Congresso
|
Phase II Studie zur simultanen Radiochemotherapie mit Cisplatin/Etoposide gefolgt von einer Erhaltungschemotherapie mit Platin/Gemcitabine bei nicht-resektablem nicht-kleinzelligem Bronchialkarzinom (NSCLC)Fink, T ; Melzner, W ; Strnad, V ; Sauer, R ; Birkenhake, S ; Ficker, JPneumologie, 2006, Vol.60 (S 1) [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Ata de Congresso
|
Randomized Phase III second-line trial: Topotecan (TM) vs. Topotecan/Etoposide (TE), vs. Topotecan/Gemcitabine (TG) for patients (pts) with relapsed ovarian cancer (ROC)Sehouli, J ; Sommer, H ; Klare, P ; Hindenburg, HJ ; Camara, O ; Lichtenegger, WGeburtshilfe und Frauenheilkunde, 2006, Vol.66 (S 01) [Periódico revisado por pares]Texto completo disponível |